Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms.

Cengiz FP, Su O, Emiroglu N, Biyik Ozkaya D, Bahali AG, Onsun N.

G Ital Dermatol Venereol. 2019 Aug;154(4):488-491. doi: 10.23736/S0392-0488.17.05151-3.

2.

Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate.

Akay AP, Kaya GÇ, Kose S, Yazıcıoğlu ÇE, Erkuran HÖ, Güney SA, Oğuz K, Keskin D, Baykara B, Emiroğlu Nİ, Eren MŞ, Kızıldağ S, Ertay T, Özsoylu D, Miral S, Durak H, Gönül AS, Rohde LA.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:294-300. doi: 10.1016/j.pnpbp.2018.04.008. Epub 2018 Apr 20.

PMID:
29684537
3.

Strengthening global health security by embedding the International Health Regulations requirements into national health systems.

Kluge H, Martín-Moreno JM, Emiroglu N, Rodier G, Kelley E, Vujnovic M, Permanand G.

BMJ Glob Health. 2018 Jan 20;3(Suppl 1):e000656. doi: 10.1136/bmjgh-2017-000656. eCollection 2018. Review.

4.

Evaluation of mean platelet volume in localized scleroderma.

Bahali AG, Su O, Emiroglu N, Cengiz FP, Kaya MO, Onsun N.

An Bras Dermatol. 2017 Sep-Oct;92(5):635-637. doi: 10.1590/abd1806-4841.20176045.

5.

Frequency and Risk Factors for Secondary Malignancies in Patients with Mycosis Fungoides.

Cengiz FP, Emiroğlu N, Onsun N.

Turk J Haematol. 2017 Dec 1;34(4):378-379. doi: 10.4274/tjh.2017.0234. Epub 2017 Aug 23. No abstract available.

6.

Cutaneous infiltration of anaplastic variant of CD30-positive diffuse large B-cell lymphoma.

Cengiz FP, Emiroglu N, Tosuner Z, Çetin G, Onsun N.

Australas J Dermatol. 2018 Feb;59(1):65-67. doi: 10.1111/ajd.12691. Epub 2017 Jul 10. No abstract available.

PMID:
28691372
7.

Evolution of Spitz Nevi.

Emiroglu N, Yıldız P, Biyik Ozkaya D, Bahalı AG, Su O, Onsun N.

Pediatr Dermatol. 2017 Jul;34(4):438-445. doi: 10.1111/pde.13184. Epub 2017 Jun 30.

PMID:
28664989
8.

Etiology of Onychomycosis in Patients in Turkey.

Cengiz FP, Cemil BC, Emiroglu N, Bahali AG, Ozkaya DB, Su O, Onsun N.

J Am Podiatr Med Assoc. 2018 May;108(3):253-256. doi: 10.7547/16-139. Epub 2017 Jun 8.

PMID:
28594608
9.

Age and Anatomical Location-Related Dermoscopic Patterns of 210 Acral Melanocytic Nevi in a Turkish Population.

Emiroglu N, Cengiz FP, Onsun N.

J Cutan Med Surg. 2017 Sep/Oct;21(5):388-394. doi: 10.1177/1203475417712496. Epub 2017 Jun 1.

PMID:
28565919
10.

Does verruca vulgaris affect social anxiety and self-esteem in adolescents?

Unal D, Cengiz FP, Emiroglu N.

Int J Adolesc Med Health. 2017 May 24;31(1). pii: /j/ijamh.2019.31.issue-1/ijamh-2016-0124/ijamh-2016-0124.xml. doi: 10.1515/ijamh-2016-0124.

PMID:
28541923
11.

Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Cutaneous Vasculitis.

Emiroglu N, Cengiz FP, Bahalı AG, Ozkaya DB, Su O, Onsun N.

Ann Clin Lab Sci. 2017 Mar;47(2):162-165.

PMID:
28442517
12.

Gabapentin-induced aquagenic wrinkling of the palms.

Emiroglu N, Cengiz FP, Su O, Onsun N.

Dermatol Online J. 2017 Jan 15;23(1). pii: 13030/qt64k739q5.

13.

Acne located on the trunk, whey protein supplementation: Is there any association?

Cengiz FP, Cevirgen Cemil B, Emiroglu N, Gulsel Bahali A, Onsun N.

Health Promot Perspect. 2017 Mar 5;7(2):106-108. doi: 10.15171/hpp.2017.19. eCollection 2017.

14.

Prognostic Evaluation of Neutrophil/Lymphocyte Ratio in Patients with Mycosis Fungoides.

Cengiz FP, Emiroglu N, Ozkaya DB, Bahali AG, Su O, Onsun N.

Ann Clin Lab Sci. 2017 Jan;47(1):25-28.

PMID:
28249912
15.

Dermoscopic Features of Small, Medium, and Large-Sized Congenital Melanocytic Nevi.

Cengiz FP, Emiroglu N, Ozkaya DB, Su O, Onsun N.

Ann Dermatol. 2017 Feb;29(1):26-32. doi: 10.5021/ad.2017.29.1.26. Epub 2017 Feb 3.

16.

Raccoon eyes in amyloidosis.

Emiroglu N, Su O, Cengiz FP, Tosuner Z, Demirkesen C, Onsun N.

G Ital Dermatol Venereol. 2017 Feb;152(1):80-82. doi: 10.23736/S0392-0488.16.05160-9. No abstract available.

PMID:
27978610
17.

The Relationship of Psoriasis and Melanocytic Nevi.

Cengiz FP, Emiroglu N, Bahali AG, Ozkaya DB, Su O, Onsun N.

Indian J Dermatol. 2016 Nov-Dec;61(6):664-667.

18.

Dermatoscopic findings of pigmented purpuric dermatosis.

Ozkaya DB, Emiroglu N, Su O, Cengiz FP, Bahali AG, Yildiz P, Demirkesen C, Onsun N.

An Bras Dermatol. 2016 Sep-Oct;91(5):584-587. doi: 10.1590/abd1806-4841.20165124.

19.

Evaluation of social anxiety, self-esteem, life quality in adolescents with acne vulgaris.

Unal D, Emiroğlu N, Cengiz FP.

Int J Adolesc Med Health. 2016 Aug 5;30(2). pii: /j/ijamh.2018.30.issue-2/ijamh-2016-0035/ijamh-2016-0035.xml. doi: 10.1515/ijamh-2016-0035.

PMID:
27508953
20.

Effectiveness and safety profile of 40% trichloroacetic acid and cryotherapy for plantar warts.

Cengiz FP, Emiroglu N, Su O, Onsun N.

J Dermatol. 2016 Sep;43(9):1059-61. doi: 10.1111/1346-8138.13370. Epub 2016 Apr 4.

PMID:
27041065
21.

Serum IL-17A in Behçet's disease.

Emiroglu N, Cengiz FP, Erdem GB.

Postepy Dermatol Alergol. 2015 Oct;32(5):358-61. doi: 10.5114/pdia.2015.54745. Epub 2015 Oct 29.

22.

Successful treatment of Melkersson-Rosenthal syndrome with dapsone: a case report and review of the literature.

Emiroglu N, Su O, Cengiz FP, Onsun N.

Dermatol Online J. 2016 Oct 15;22(10). pii: 13030/qt4zz1g8t1. Review.

PMID:
28329598
23.

Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases.

Akay AP, Kaya GC, Baykara B, Demir Y, Özek H, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan E.

Neuropsychiatr Dis Treat. 2015 Nov 19;11:2909-12. doi: 10.2147/NDT.S87359. eCollection 2015.

24.

Dermoscopic and clinical features of head and neck melanoma.

Cengiz FP, Cengiz AB, Emiroglu N, Comert E, Wellenhof RH.

An Bras Dermatol. 2015 Jul-Aug;90(4):488-93. doi: 10.1590/abd1806-4841.20153341.

25.

Insulin resistance in severe acne vulgaris.

Emiroğlu N, Cengiz FP, Kemeriz F.

Postepy Dermatol Alergol. 2015 Aug;32(4):281-5. doi: 10.5114/pdia.2015.53047. Epub 2015 Aug 12.

26.

The relation between dermoscopy and histopathology of basal cell carcinoma.

Emiroglu N, Cengiz FP, Kemeriz F.

An Bras Dermatol. 2015 May-Jun;90(3):351-6. doi: 10.1590/abd1806-4841.20153446. Epub 2015 Jun 1.

27.

Dermoscopic and clinical features of pigmented skin lesions of the genital area.

Cengiz FP, Emiroglu N, Wellenhof RH.

An Bras Dermatol. 2015 Mar-Apr;90(2):178-83. doi: 10.1590/abd1806-4841.20153294.

28.

Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides.

Cengiz FP, Emiroglu N.

An Bras Dermatol. 2015 Jan-Feb;90(1):36-40. doi: 10.1590/abd1806-4841.20153352.

29.

Dermoscopic and clinical features of trunk melanomas.

Emiroglu N, Pelin Cengiz F, Hofmann-Wellenhof R.

Postepy Dermatol Alergol. 2014 Dec;31(6):362-7. doi: 10.5114/pdia.2014.47119. Epub 2014 Dec 3.

30.

Challenges of maintaining polio-free status of the European Region.

Khetsuriani N, Pfeifer D, Deshevoi S, Gavrilin E, Shefer A, Butler R, Jankovic D, Spataru R, Emiroglu N, Martin R.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S194-207. doi: 10.1093/infdis/jiu096.

PMID:
25316836
31.

An open, comparative clinical study on the efficacy and safety of 10% trichloroacetic acid, 25% trichloroacetic acid and cryotherapy for verruca plana.

Cengiz FP, Emiroglu N.

Cutan Ocul Toxicol. 2015;34(2):144-8. doi: 10.3109/15569527.2014.924961. Epub 2014 Jun 18.

PMID:
24938453
32.

A cohesive European policy for hepatitis B vaccination, are we there yet?

Lernout T, Hendrickx G, Vorsters A, Mosina L, Emiroglu N, Van Damme P.

Clin Microbiol Infect. 2014 May;20 Suppl 5:19-24. Epub 2014 Jan 19. Review.

33.

Effects of sociodemographic factors and maternal anxiety on preoperative anxiety in children.

Cagiran E, Sergin D, Deniz MN, Tanattı B, Emiroglu N, Alper I.

J Int Med Res. 2014 Apr;42(2):572-80. doi: 10.1177/0300060513503758. Epub 2014 Feb 5.

PMID:
24501165
34.

Risk factors for low vaccination coverage among Roma children in disadvantaged settlements in Belgrade, Serbia.

Stojanovski K, McWeeney G, Emiroglu N, Ostlin P, Koller T, Licari L, Kaluski DN.

Vaccine. 2012 Aug 10;30(37):5459-63. doi: 10.1016/j.vaccine.2012.06.072. Epub 2012 Jul 6.

PMID:
22776215
35.

A case with unexplained bleeding from multiple sites: munchausen syndrome by proxy.

Tüfekçi Ö, Gözmen S, Yılmaz Ş, Hilkay Karapınar T, Çetin B, Burak Dursun O, Emiroğlu N, Ören H, Irken G.

Pediatr Hematol Oncol. 2011 Aug;28(5):439-43. doi: 10.3109/08880018.2011.565493.

PMID:
21736476
36.

Supplementary immunization activities to achieve measles elimination: experience of the European Region.

Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N.

J Infect Dis. 2011 Jul;204 Suppl 1:S343-52. doi: 10.1093/infdis/jir074.

PMID:
21666183
37.

What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.

Martin R, Wassilak S, Emiroglu N, Uzicanin A, Deshesvoi S, Jankovic D, Goel A, Khetsuriani N.

J Infect Dis. 2011 Jul;204 Suppl 1:S325-34. doi: 10.1093/infdis/jir137.

PMID:
21666181
38.

Maternal reactions to a child with epilepsy: Depression, anxiety, parental attitudes and family functions.

Pekcanlar Akay A, Hiz Kurul S, Ozek H, Cengizhan S, Emiroglu N, Ellidokuz H.

Epilepsy Res. 2011 Aug;95(3):213-20. doi: 10.1016/j.eplepsyres.2011.03.020. Epub 2011 May 2.

PMID:
21543187
39.

Depression and anxiety in children and adolescents with familial Mediterranean fever.

Makay B, Emiroğlu N, Unsal E.

Clin Rheumatol. 2010 Apr;29(4):375-9. doi: 10.1007/s10067-009-1330-9. Epub 2009 Dec 22.

PMID:
20033242
40.

Rotavirus burden among children in the newly independent states of the former union of soviet socialist republics: literature review and first-year results from the rotavirus surveillance network.

Mirzayeva R, Cortese MM, Mosina L, Biellik R, Lobanov A, Chernyshova L, Lashkarashvili M, Turkov S, Iturriza-Gomara M, Gray J, Parashar UD, Steele D, Emiroglu N; Rotavirus Surveillance Network.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S203-14. doi: 10.1086/605041.

PMID:
19817601
41.

Immunization: mind the gap.

Jagessar N, Lazarus JV, Laurent E, Matic S, Emiroglu N.

Vaccine. 2008 Dec 9;26(52):6736-7. doi: 10.1016/j.vaccine.2008.07.087. Epub 2008 Aug 14. No abstract available.

PMID:
18706950
42.

Measles outbreak in the Ukraine, 2005-2006.

Spika JS, Aidyralieva C, Mukharskaya L, Kostyuchenko NN, Mulders M, Lipskaya G, Emiroglu N.

Euro Surveill. 2006 Mar 9;11(3):E060309.1. No abstract available.

PMID:
16804226
43.

Effects of long-term methylphenidate treatment: a pilot follow-up clinical and SPECT study.

Akay AP, Kaya GC, Emiroğlu NI, Aydin A, Monkul ES, Taşçi C, Miral S, Durak H.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1219-24. Epub 2006 Apr 17.

PMID:
16616981
44.

Hepatitis B immunisation in Britain: time to change?

Banatvala J, Van Damme P, Emiroglu N.

BMJ. 2006 Apr 8;332(7545):804-5. No abstract available.

45.

Vaccine safety controversies and the future of vaccination programs.

François G, Duclos P, Margolis H, Lavanchy D, Siegrist CA, Meheus A, Lambert PH, Emiroğlu N, Badur S, Van Damme P.

Pediatr Infect Dis J. 2005 Nov;24(11):953-61. Review.

PMID:
16282928
46.

Preventing congenital rubella infection in the European Region of WHO: 2010 target.

Spika JS, Hanon FX, Wassilak S, Pebody R, Emiroglu N.

Euro Surveill. 2004 Apr;9(4):4-5.

PMID:
15192255
47.

Preventing congenital rubella infection in the European Region of WHO: 2010 target.

Spika JS, Hanon FX, Wassilak S, Pebody RG, Emiroglu N.

Euro Surveill. 2004 Apr;9(4):3-4. doi: 10.2807/esm.09.04.00455-en.

PMID:
29183454
48.

WHO European Region's strategy for elimination of measles and congenital rubella infection.

Hanon FX, Spika John J, Wassilak Steven S, Emiroglu N.

Euro Surveill. 2003 Jun;8(6):129-30.

PMID:
12878802
49.

Measles-rubella mass immunization campaign in Albania, November 2000.

Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A.

J Infect Dis. 2003 May 15;187 Suppl 1:S223-9.

PMID:
12721917
50.

Measles and rubella in the World Health Organization European region: diversity creates challenges.

Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.

J Infect Dis. 2003 May 15;187 Suppl 1:S191-7. Review.

PMID:
12721913

Supplemental Content

Loading ...
Support Center